OCLG.US Oncologix Tech Inc
- Market cap
- USD 166K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Aug 2023.
Is OCLG.US undervalued?
Graham numberThe Graham number of Oncologix Tech Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Oncologix Tech Inc fundamental analysis
No fundamental analysis for Oncologix Tech Inc yet.
Oncologix Tech Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Oncologix Tech Inc
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilitie…
Full company profileOncologix Tech Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 4 quarters up to Aug 31, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Oncologix Tech Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 244K | 3.68M | 4.90M | 4.01M | 2.85M | - | - | - | - | - |
| Gross Profit | 0.00 | 48.5K | 614K | 1.37M | 1.22M | 572K | - | - | - | - | - |
| Operating Income | -131K | -287K | -572K | -509K | -512K | -865K | - | - | - | - | - |
| EBITDA | -131K | -462K | -576K | -923K | -1.14M | -1.11M | - | - | - | - | - |
| Net Income | -286K | -653K | -1.31M | -2.55M | -1.85M | -2.37M | - | - | - | - | - |
| EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | - | - | - | - | - |
| Balance Sheet | |||||||||||
| Total Assets | 6.41K | 2.03M | 2.14M | 3.13M | 2.15M | 1.50M | - | - | - | - | - |
| Total Liabilities | 594K | 2.39M | 2.80M | 4.95M | 5.77M | 7.47M | 6.67M | 6.67M | 6.67M | - | - |
| Shareholders' Equity | -584K | -357K | -665K | -1.82M | -3.62M | -5.97M | -6.67M | -6.67M | -6.67M | 1.66M | - |
| Cash & Short-term Investments | 1.93K | 39.5K | 17.5K | 25.0K | 60.2K | 30.8K | - | - | - | - | - |
| Total Debt | 125K | 1.07M | 1.91M | 3.41M | 4.45M | 5.16M | 3.04M | 3.04M | 3.04M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -119K | 147K | -630K | -357K | 345K | -24.2K | - | - | - | - | - |
| Capital Expenditure | 1.68K | 878.00 | 878.00 | 3.26K | 913.00 | 913.00 | - | - | - | - | 0.00 |
| Free Cash Flow | -121K | 147K | -631K | -360K | 345K | -25.1K | - | - | - | - | - |
| Ratios | |||||||||||
| ROA | -4,465.3% | -32.1% | -61.4% | -81.5% | -85.9% | -158.6% | - | - | - | - | - |
| Net Profit Margin | - | -267.4% | -35.7% | -52.1% | -46.1% | -83.2% | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Oncologix Tech Inc dividends
Oncologix Tech Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:4 on May 19, 2011.
Who owns Oncologix Tech Inc
Ownership data of Oncologix Tech Inc is not available yet.
Oncologix Tech Inc company profile
- Company name
- Oncologix Tech Inc
- Ticker
- OCLG.US
- Exchange
- USA Stocks
- Listed since
- Mar 9, 1987
- Sector
- Financial Services
- Industry
- Health Care Providers & Services
- Employees
- 191
- Fiscal year end
- August
- Address
- 1604 West Pinhook Drive, Lafayette, LA, United States, 70508
- Phone
- 616-977-9933
- Website
- oclghealth.com
About Oncologix Tech Inc
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers. In addition, it distributes and sells home medical equipment for sleep and respiratory therapies; supplies and services durable medical equipment to treat obstructive Sleep Apnea; C-PAP and BiPAP oxygen equipment, a large selection of mask interfaces; and offers personalized treatment plans, as well as monitoring and support services. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.
Oncologix Tech Inc management
3- Mr. Michael A. KramarzChairman of the Board, CEO, CFO & Secretary · born 1970
- Mr. Harold HalmanCOO & Director
- Ms. Nikole JessieDirector of Marketing & Public Relations